Compare UGRO & NUWE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | UGRO | NUWE |
|---|---|---|
| Founded | 2014 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Specialties | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.5M | 2.9M |
| IPO Year | N/A | N/A |
| Metric | UGRO | NUWE |
|---|---|---|
| Price | $3.79 | $1.97 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $75.00 | N/A |
| AVG Volume (30 Days) | 48.3K | ★ 6.4M |
| Earning Date | 02-10-2026 | 03-10-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $23,942,741.00 | $8,167,999.00 |
| Revenue This Year | $98.41 | N/A |
| Revenue Next Year | $23.34 | $10.48 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $2.84 | $1.71 |
| 52 Week High | $21.50 | $62.16 |
| Indicator | UGRO | NUWE |
|---|---|---|
| Relative Strength Index (RSI) | 87.29 | 40.44 |
| Support Level | $0.11 | $2.42 |
| Resistance Level | $4.50 | $4.47 |
| Average True Range (ATR) | 0.21 | 0.59 |
| MACD | 0.38 | -0.16 |
| Stochastic Oscillator | 74.24 | 1.34 |
Urban-gro Inc operated as an integrated professional services and design-build firm offering architectural, engineering, and construction management solutions to the CEA, industrial, healthcare, and other commercial sectors. The company generated revenue by billing employees time on client projects and provided architectural, engineering, systems procurement and integration, and construction design-build solutions with a single point of accountability. For CEA clients, it developed indoor cultivation facilities for specialty crops, including cannabis and produce such as leafy greens, vegetables, herbs, and berries. Its segments included Equipment Systems (commercial horticulture equipment), Services (design-build services), and Construction Design-Build (general contracting).
Nuwellis Inc is a medical technology company focused on developing, manufacturing, and commercializing a medical device used in ultrafiltration therapy, including the Aquadex FlexFlow and the Aquadex SmartFlow systems. The Aquadex Smartflow System removes excess fluid from patients suffering from fluid overload who have not responded to medical management, including diuretics. Nuwellis has one reportable segment: fluid overload.